SARS-CoV-2 vaccine (Metaclipse Therapeutics)

N/A

Report date: 2025/01/26 16:48:03

Base Information

Drug NameSARS-CoV-2 vaccine (Metaclipse Therapeutics)
Drug Alias NameCOVID-19 vaccine (Metaclipse Therapeutics)SARS-CoV-2 vaccine (Metaclipse Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCytokines modulators
TargetsCytokines
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetaclipse Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesMetaclipse Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A